Bioactive substances from myxobacteria

Korean Journal of Microbiology and Biotechnology

Volumn 31, Issue 1, 2003, Pages 1-12

  Kim, Yong Seok ^a   Bae, Woo Chul ^a   Baek, Seong Jin ^a  

^a Ilyang Pharm Co Ltd   (South Korea)

Author keywords

Fermentation; Isolation; Myxobacteria; Source of bioactive compounds

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ALTHIOMYCIN; AMBRUTICIN; AMBRUTICIN VS; ANGIOLAM; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; AURACHIN A; AURACHIN B; AURACHIN C; AURACHIN D; CORALLOPYRONIN; ENZYME INHIBITOR; GLIDOBACTIN; MEGOVALICIN; MYXALAMID; MYXOCHELIN A; MYXOPYRONIN; MYXOTHIAZOL; MYXOVALARGIN; NANNOCHELIN; PHENALAMID; PHENOXAN; PYRROLNITRIN; RNA POLYMERASE; SAFRAMYCIN MX1; SORANGICIN; STIGMATELLIN; STIPIAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; CYTOSKELETON; DRUG ACTIVITY; DRUG DECOMPOSITION; DRUG ISOLATION; DRUG STRUCTURE; ELECTRON TRANSPORT; LIFE CYCLE; MITOCHONDRIAL RESPIRATION; MYXOCOCCALES; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

MYXOCOCCALES;

EID: 0141955191     PISSN: 1598642X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Ahn, J. W. and C. O. Lee. 2002. Isolation and properties of cytotoxic antibiotics from Myxococcus stipitatus JW150. Yakhak Hoeji. 46: 108-112.
2. Ahn, J. W., S. H. Woo, C. O. Lee, K. Y. Cho, and B. S. Kim. 1999. KR025, a new cytotoxic compound from Myxococcus fulvus. J. Nat. Prod. 62: 495-496.
3. Burchard, A. C., P. R. Burchard, and J. A. Kloetzel. 1977. Intracellular, periodic structures in the gliding bacterium Myrococcus xanthus. J. Bacteriol. 132: 666-672.
4. Daoud, N. N. and H. A. Foster. 1993. Antifungal activity of Myxococcus species 1 production, physicochemical and biological properties of antibiotics from Myxococcus fulvus S110 (Myxobacterales). Microbios. 73: 173-184.
5. Dawid, W. 2000. Biology and global distiribution of myxobacteria in soils. FEMS Microbiol. Rev. 24: 403-427.
6. Dhundale, A. R., T. Furuichi, S.Inouye, and M. Inouye. 1985. Distribution of multicopy single stranded DNA among myxobacteria and related species. J. Bacteriol. 164: 914-917.
7. Dworkin, M. 1996. Recent advances in the social and developmental biology of the myxobacteria. Microbiol. Rev. 60: 70-102.
8. Fudou, R., T. Iizuka, S. Sato, T. Ando, N. Shimba, and S. Yamanaka. 2000. Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 2. Isolation and structural elucidation. J. Antibiot. 54: 153-156.
9. Gerth, K., D. Schummer, G. Hofle, H. Irschik, and H. Reichenbach. 1995. Ratjadon: a new antifungal compound from Sorangium cellulosum (myxobacteria) production, physio-chemical and biological properties. J. Antibiot. 48: 973-976.
10. Gerth, K., H. Irschik, H. Reichenbach, and W. Trowitzsch. 1980. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties. J. Antibiot. 33: 1474-1479.
11. Gerth, K., N. Bedorf, G. Hofle, H. Irschik, and H. Reichenbach. 1996. Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties. J. Antibiot. 49: 560-563.
12. Gerth, K., N. Bedorf, H. Irschik, G. Hofle, and H. Reichenbach. 1994. The soraphens: a family of novel antifungal compounds from Sorangium cellulosum (Myxobacteria). I. Soraphen A1 alpha: fermentation, isolation, biological properties. J. Antibiot. 47: 23-31.
13. Gerth, K., P. Washausen, G. Hofle, H. Irschik, and H. Reichenbach. 1996. The jerangolids: A family of new antifungal compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties of jerangolid A. J. Antibiot. 49: 71-75.
14. Gerth, K., R. Jansen, G. Reifenstahl, G. Hofle, H. Irschik, B. Kunze, H. Reichenbach, and G. Thierbach. 1983. The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action. J. Antibiot. 36: 1150-1156.
15. Gerth, K., W. Trowitzsch, V. Wray, G. Hofle, H. Irschik, and H. Reichenbach. 1982. Pyrrolnitrin from Myxococcus fulvus (Myxobacterales). J. Antibiot. 35: 1101-1103.
16. Gerth. K., H. Irschik, H. Reichenbach, and W. Trowitzsch. 1982. The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales). J Antibiot. 35: 1454-1459.
17. Gnosspelius, G. 1978. Myxobacterial slime and proteolytic activity. Arch. Microbiol. 116: 51-59.
18. Hofle, G., H. Steinmetz, K. Gerth, and H. Reichenbach. 1991. Ambruticin VS: new members of the antifungal ambruticin family from Sorangium cellulosum. Just. Liebigs Ann. Chem. 1991: 941-945.
19. Inouye, S., P.J. Herzer, and M. Inouye. 1990. Two independent retrons with highly diverse reverse transcriptases in Myxococcus xanthus. Proc. Natl. Acad. Sci. USA. 87: 942-945.
20. Irschik, H., D. Schummer, K. Gerth, G. Hofle, and H. Reichenbach. 1995. The tartrolons, new boron-containing antibiotics from a myxobacterium, Sorangium cellulosum. J. Antibiot. 48: 26-30.
21. Irschik, H. and H. Reichenbach. 1985. An unusual pattern of carbohydrate utilization in Corallococus coralloides Cc c127. Arch. Microbiol. 142: 40-44.
22. Irschik, H., H. Augustiniak, K. Gerth, G. Hofle, and H. Reichenbach. 1995. The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J. Antibiot. 48: 787-792.
23. Irschik, H., K. Gerth, G. Hofle, W. Kohl, and H. Reichenbach. 1983. The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcusfulvus (Myxobacterales). J. Antibiot. 36: 1651-1658.
24. Irschik, H., K. Gerth, T. Kemmer, H. Steinmetz, and H. Reichenbach. 1983. The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, and some chemical and biological properties. J Antibiot. 36: 6-12.
25. Irschik, H., R. Jansen, G. Hofle, K. Gerth, and H. Reichenbach. 1985. The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria. J Antibiot. 38: 145-152.
26. Irschik, H., R. Jansen, K. Gerth, G. Hofle, and H. Reichenbach. 1987. The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria. J. Antibiot. 40: 7-13.
27. Irschik, H., R. Jansen, K. Gerth, G. Hofle, and H. Reichenbach. 1995. Disorazol A, an efficient inhibitor of eukaryotic organisms isolated from myxobacteria. J. Antibiot. 48: 31-35.
28. Irschik, H., R. Jansen, K. Gerth, G. Hofle, and H. Reichenbach. 1995. Chivosazol A, a new inhibitor of eukaryotic organisms isolated from myxobacteria. J. Antibiot. 48: 962-966.
29. Irschik, H., R. Jansen, K. Gerth, G. Hofle, and H. Reichenbach. 1995. Sorangiolid A, a new antibiotic isolated from the myxobacterium Sorangium cellulosum So ce 12. J. Antibiot. 48: 886-887.
30. Irschik, H., W. Trowitzsch-Kienast, K. Gerth, G. Hofle, and H. Reichenbach. 1988. Saframycin Mx1, a new natural saframycin isolated from a myxobacterium. J. Antibiot. 41: 993-998.
31. Jansen, R., P. Washausen, B. Kunze, H. Reichenbach, and G. Hofle. 1999. The crocacins, novel antifungal and cytotoxic antibiotics from Chondromyces crocatus and Chondromyces pediculatus (myxobacteria): isolation and structure elucidation. Eur. J. Org. Chem. 1999: 1075-1080.
32. Kim, Y. J., K. Furihata, S. Yamanaka, R. Fudo, and H. Seto. 1991. Isolation and structural elucidation of stipiamide, a new antibiotic effective to multidrug-resistant cancer cells. J. Antibiot. 44: 553-556.
33. Kunze, B., G. Hofle, and H. Reichenbach. 1987. The aurachins, new quinoline antibiotics from myxobacteria: production, physico-chemical and biological properties. J. Antibiot. 40: 258-265.
34. Kunze, B., H. Reichenbach, H. Augustiniak, and G. Hofle. 1982. Isolation and identification of althiomycin from Cystobacter fuscus (myxobacterales). J. Antibiot. 35: 635-636.
35. Kunze, B., N. Bedorf, W. Kohl, G. Hofle, and H. Reichenbach. 1989. Myxochelin A, a new iron-chelating compound from Angiococcus disciformis (Myxobacterales). Production, isolation, physico-chemical and biological properties. J. Antibiot. 42: 14-17.
36. Kunze, B., R. Jansen, F. Sasse, G. Hofle, and H. Reichenbach. 1995. Chondramides A approximately D, new antifungal and cytostatic depsipeptides from Chondromyces crocatus (myxobacteria). Production, physico-chemical and biological properties. J Antibiot. 48: 1262-1266.
37. Kunze, B., R. Jansen, F. Sasse, G. Hofle, and H. Reichenbach. 1998. Apicularens A and B, new cytostatic macrolides from Chondromyces species (myxobacteria): production, physico-chemical and biological properties. J. Antibiot. 51: 1075-1080.
38. Kunze, B., R. Jansen, G. Hofle, and H. Reichenbach. 1994. Crocacin, a new electron transport inhibitor from Chondromyces crocatus (myxobacteria). Production, isolation, physico-chemical and biological properties. J. Antibiot. 47: 881-886.
39. Kunze, B., R. Jansen, L. Pridzun, E. Jurkiewicz, G. Hunsmann, G. Hofle, and H. Reichenbach. 1992. Phenoxan, a new oxazole-pyrone from myxobacteria: production, antimicrobial activity and its inhibition of the electron transport in complex I of the respiratory chain. J. Antibiot. 45: 1549-1552.
40. Kunze, B., T. Kemmer, G. Hofle, and H. Reichenbach. 1984. Stigmatellin, a new antibiotic from Stigmatella aurantiaca (Myxobacterales). I. Production, physico-chemical and biological properties. J. Antibiot. 37: 454-461.
41. Kunze, B., W. Kohl, G. Hofle, and H. Reichenbach. 1985. Production, isolation, physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales). J. Antibiot. 38: 1649-1654.
42. Kunze, B., W. Trowitzsch-Kienast, G. Hofle, and H. Reichenbach. 1992. Nannochelins A, B and C, new iron-chelating compounds from Nannocystis exedens (myxobacteria). Production, isolation, physico-chemical and biological properties. J. Antibiot. 45: 147-150.
43. Kwon, H. J., D. H. Kim, J. S. Shim, and J. W. Ahn. 2002. Apicularen A, a macrolide from Chondromyces sp., inhibits growth factor induced in vitro angiogenesis. J. Microbiol. Biotechnol. 12: 702-705.
44. Lampky, J. R. 1976. Ultrastructure of Polyangium cellulosum. J. Bacteriol. 126: 1278-1284.
45. Lampson B. C., M. Inouye, and S. Inouye. 1991. Survey of multicopy single-stranded DNAs and reverse transcriptase gene among natural isolates of Myxococcus xanthus. J Bacteriol. 173: 5363-5370.
46. Li, E., A. M. Clark, D. P. Rotella, and C. D. Hufford. 1995. Microbial metabolites of ophiobolin A and antimicrobial evaluation of ophiobolins. J. Nat. Prod. 58: 74-81.
47. Ludwig, W., K.H. Schleifer, H. Reichenbach, and E. Stackebrandt. 1983. A phylogenetic analysis of the myxobacteria Myxococcus fulvus, Stigmatella aurantic, Cystobacter fuscus, Sorangium cellulosum and Namocystis exedens. Arch. Microbiol. 135: 58-62.
48. Lunsdorg, H. and H. Reichenbach. 1989. Ultrastructural details of the apparatus of gliding mobility of Myxococcus fulvus (Myxobacterales). J. Gen. Microbiol. 135: 1633-1641.
49. MacRae, T. H. and H. D. McCurdy. 1975. Ultrastructural studies of Chondromyces crocatus vegetative cells. Can. J. Microbiol. 21: 1815-1826.
50. Masson, P. J. and J. F. Guespin-Michel. 1988. An extracellular blood-anticoagulant glycopeptide produced exclusively during vegetative growth by Myxococcus xanthus and other myxobacteria is not co-regulated with other extracellular macromolecules. J. Gen. Microbiol. 134: 801-806.
51. Mayer, H. and H. Reichenbach. 1978. Restriction endonucleases: general survey procedure and survey of gliding bacteria. J. Bacteriol. 1362: 708-713.
52. Ojika, M., Y. Suzuki, A. Tsukamoto, Y. Sakagami, R. Fudou, T. Yoshimura, and S. Yamanaka. 1998. Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium Cystobacter fuscus. J. Antibiot. 51: 275-281.
53. Oka, M., Y. Nishiyama, S. Ohta, H. Kamei, M. Konishi, T. Miyaki, T. Oki, and H. Kawaguchi. 1988. Glidobactins A, B and C, new antitumor antibiotics. I. Production, isolation, chemical properties and biological activity. J. Antibiot. 41: 1331-1337.
54. Petit, F. and J. F. Guespin-Michel. 1992. Production of an extracellular milk-clotting activity during development in Myxococcus xanthus. J. Bacteriol. 174: 5136-5240.
55. Reichenbach, H. 1999. Myxobacteria, pp 1822-1832. In M. C. Flickinger and S. W. Drew (eds), The Encyclopedia of Bioprocess Technology: Fermentation, Biocatalysis, and Bioseperation, John Wiley and Sons, New York.
56. Reichenbach, H. 2001. Myxobacteria, a producers of novel bioactive substances. J. Ind. Microbial. Biotechnol. 27: 149-156.
57. Reichenbach, H. and Dworkin, M. 1991. The myxobacteria. pp 3415-3487. In K. P. Starr, H. Stolp, H. G. Truper, A. Belows. and H. E. Schlegel (eds), The Prokaryotes, vol. 4, Springer, New York.
58. Reichenbach, H. and G. Hofle. 1993. Biologically active secondary metabolites from myxobacteria. Biotech. Adv. 11: 219-277.
59. Reichenbach, H. and G. Hofle. 1993. Production of bioactive secondary metabolites, pp347-395. In M. Dworkin and D. Kaiser (eds), Myxobacteria II, Am. Soc. Microbiol. Press, Washington.
60. Reichenbach, H. and M. Dworkin. 1969. Studies on Stigmatella aurantiaca (Myxobacterales). J. Gen. Microbiol. 58: 3-14.
61. Reichenbach. H. and G. Hofle. 1999. Myxobacteria as a producers of secondary metabolites, pp 149-179. In S. Grabley and R. Thiericke (eds), Drug Discovery from Nature, Springer-Verlag, Berlin.
62. Ringel, S.M., R.C. Greenough, S. Roemer, D. Connor, A. L. Gutt, B. Blair, G. Kanter, and M. von Strandtmann. 1977. Ambruticin (W7783), a new antifungal antibiotic. J. Antibiot. 30: 371-375.
63. Sasse, F. B. Bohlendorf, M. Hermann, B. Kunze, E. Forche, H. Steinmetz, G. Hofle, and H. Reichenbach. 1999. Melithizols, new methoxyacrylate inhibitors of the respiratory chain isolated from myxobacteria. Production, isolation, physico-chemical and biological properties. J. Antibiot. 52: 721-729.
64. Sasse, F., B. Kunze, T. M. A. Groneworld, and H. Reichenbach. 1998. The chondramides: cytostatic agent from myxobacteria acting on the actin cytoskeleton. J. Natl. Cand. Inst. 90: 1559-1563.
65. Sasse, F., H. Steinmetz, G. Hofle, and H. Reichenbach. 1993. Rhizopodin, a new compound from Myxococcus stipitatus (myxobacteria) causes formation of rhizopodia-like structures in animal cell cultures. Production, isolation, physicochemical and biological properties. J. Antibiot. 46: 741-748.
66. Sasse, F., H. Steinmetz, G. Hofle, and H. Reichenbach. 1995. Gephyronic acid, a novel inhibitor of eukaryotic protein synthesis from Archangium gephyra (myxobacteria). Production, isolation, physico-chemical and biological properties, and mechanism of action. J. Antibiot. 48: 21-25.
67. Sasse, F., H. Steinmetz, J. Heil, G. Hofle, and H. Reichenbach. 2000. Tubulysins, new cytostatic peptides from myxobacteria acting on microtubuli. Production, isolation, physicochemical and biological properties. J. Antibiot. 53: 879-885.
68. Sasse, F., H. Steinmetz, T. Schupp, F. Petersen, K. Memmert, H. Hofmann, C. Heusser, V. Brinkmann, P. von Matt, G. Hofle, and H. Reichenbach. 2002. Argyrins, immunosuppressive cyclic peptides from myxobacteria. I. Production, isolation, physico-chemical and biological properties. J. Antibiot. 55: 543-551.
69. Shimekets, L. and C. R. Woese. 1992. A phylogenetic analysis of the myxobacteria: basis for the classification. Proc. Natl. Acad. Sci. USA. 89: 9459-5463.
70. Singh, B. N. 1947. Myxobacteia in soils and composts; their distribution, number and lytic acition on bacteria. J. Gen. Microbiol. 1: 1-10.
71. Suzuki, Y., M. Ojika, Y. Sakagami, R. Fudou, and S. Yamanaka. 1998. Cystothiazoles C-F, new new bithiazole-type antibiotics from the myxobacterium Cystobacter fuscus. Tetrahedron. 54: 11399-11404.
72. Takayama, S,. S. Yamanaka, S. Miyashiro, Y. Yokokawa, and H. Shibai. 1988. Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. II. Isolation and chemical structures of megovalicins. J. Antibiot. 41: 439-445.
73. Trowitz-Kienast, W., E. Forche, V. Wray, E. Jurkiewicz, G. Hunsmann, and G. Hofle. 1992. Phenalamid, neue HIV-1 inhibitoen aus Myxococcus stipitatus Mx s40. Just. Liebigs Ann. Chem. 1992: 659-664.
74. Trowitz-Kienast, W., E. Forche, V. Wray, E. Jurkiewicz, G. Hunsmann, and G. Hofle. 1992. Thiangazol, a novel inhibitory HIV-1 infection in cell cultures from Polyangium sp. Just. Liebigs Ann. Chem. 1992: 357-359.
75. Xia, D., C. A. Yu, H. Kim, J. Z. Xia, A. M. Kachurin, L. Zhang, L. Yu, and J. Deisenhofer. 1997. Crystal structure of the cytochrome bcl-complex from bovine heart mitochondria. Science. 277: 60-66.
76. Zhang, W., J. Munoz-Dorado, M. Inouye, and S. Inouye. 1992. Identification of a putative eukaryotic-like protein kinase family in the developmental bacterium Myxococcus xanthus. J. Bacteriol. 174: 5450-5453.